Comparison three-dimensional conformal radiotherapy versus intensity modulated radiation therapy in local control of head and neck cancer.

Background: About 74% of head and neck cancer (HNC) patients need to undergo either definitive or postoperative radiation therapy because of aggressive nature of disease. The transition from two-dimensional conventional radiotherapy to three-dimensional conformal radiotherapy (3D-CRT) and further te...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Cancer Research & Therapeutics Vol. 14; no. 4; pp. 1412 - 1418
Autores principales: Ghosh, Gopa, Gupta, Gaurav, Malviya, Anupam, Saroj, Dinesh
Formato: Journal Article
Publicado: Wolters Kluwer India Pvt Ltd Oct2018
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=133277310&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 133277310
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        09731482
        1BS3
      jtl: Journal of Cancer Research & Therapeutics
      issn: 09731482
      maglogo: N
    pubinfo:
      dt: Oct2018
      vid: 14
      iid: 4
      pid: 16919
      pub: Wolters Kluwer India Pvt Ltd
    artinfo:
      ui:
        133277310
        133277310
        NLM30488865
        10.4103/jcrt.JCRT_725_17
        NLM30488865
        133277310
      ppf: 1412
      ppct: 6
      formats:
      tig:
        atl: Comparison three-dimensional conformal radiotherapy versus intensity modulated radiation therapy in local control of head and neck cancer.
      aug:
        au:
          Ghosh, Gopa
          Gupta, Gaurav
          Malviya, Anupam
          Saroj, Dinesh
        affil: Department of Radiotherapy, Chirayu Medical College and Hospital, Bhopal, Madhya Pradesh, India
      sug:
        subj:
          Head and Neck Neoplasms Pathology
          Head and Neck Neoplasms Radiotherapy
          Postoperative Care Methods
          Mouth Neoplasms Radiotherapy
          Xerostomia Radiotherapy
          Female
          Xerostomia Drug Therapy
          Prospective Studies
          Middle Age
          Cisplatin Therapeutic Use
          Radiotherapy, Conformal Methods
          Radiation Dosage
          Prognosis
          Xerostomia Pathology
          Male
          Radiotherapy, Computer-Assisted Methods
          Mouth Neoplasms Drug Therapy
          Head and Neck Neoplasms Drug Therapy
          Scales
          Middle Aged: 45-64 years
          Female
          Male
      ab: Background: About 74% of head and neck cancer (HNC) patients need to undergo either definitive or postoperative radiation therapy because of aggressive nature of disease. The transition from two-dimensional conventional radiotherapy to three-dimensional conformal radiotherapy (3D-CRT) and further technological evolutions led to the successful clinical implementation of intensity modulated radiation therapy (IMRT), which constitutes an evolution of 3D-CRT. The IMRT technique gives the ability to create treatment fields with varying beam intensity using inverse planning and optimization algorithms to treat irregularly shaped target volumes with high precision. IMRT is in existence in clinical practice since 1995. Since then, presuming its clinical benefit a significant amount of patients has been treated by this technique. PARSPORT was the first multi-institutional prospective trial comparing IMRT with conventional RT in the treatment of HNC. It has shown a reduction in severe xerostomia but no difference in other toxicity and locoregional control after 24 months' follow or overall survival. Except for early T1, 2 N0 stages, the prognosis for patients with oral cavity cancer (OCC) is dismal than for carcinoma in other sites of the head and neck (HNC).Aim: The aim of this study was to assess the outcome of OCC following IMRT.Materials and Methods: Between January 2013 and January 2015, 40 patients of carcinoma buccal mucosa and carcinoma alveolus were treated by postoperative (19) or definitive (21) radiation therapy by IMRT technique. Of these, 28 patients (70%) presented with locally advanced T3/4 or recurrent tumor. Total radiation doses delivered was between 60 and 70 Gray at 2 Gray/fraction. Of these 31 patients (78%) has received concurrent cisplatin-based chemotherapy. Another group of 42 similar patients treated by 3D-CRT as definitive or postoperative adjuvant treatment over the same period has been selected. Comparisons were performed between these two groups.Statistical Analysis: Data were entered into Excel spreadsheet and expressed as mean and standard deviation for deriving P value, and unpaired t-test was used to calculate 95% confidence interval. Local control (LC) was analyzed using Kaplan-Meier curve. Of all assessed treatment subgroups, LC rate was highest for patients treated with postoperative IMRT (89% LC at 2 years) followed by postoperative 3D-CRT patients (79% LC at 2 years); and finally, poorest LC rates (43% and 32% at 2 years) were seen in definitively irradiated patients with IMRT and 3D-CRT, respectively. LC rate for T1 stage (83%, n = 6) was significantly higher, than that for T2-4 (LC 55%, n = 76) as expected.Conclusion: Postoperative IMRT of carcinoma buccal mucosa and alveolus resulted in the highest LC rate of all the treatment subgroups assessed hence should be generously recommended in such cases especially ones with unfavorable features such as close resection margin, nodal involvement, locally advanced tumor (>T1N0), or recurrent disease, respectively. Despite definitive IMRT, locoregional control in carcinoma buccal mucosa and alveolus remain unsatisfactory, comparable to that following definitive 3D-CRT.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N